Empowered Patient Podcast

Paul Hickey, President and CEO of ReShape Lifesciences, discusses the company's role in the weight loss industry. The ReShape Lap-Band® and the new ReShape Lap-Band® 2.0 FLEX are tested surgical options for weight loss and weight management and are now being joined in the market by GLP-1 agonists such as Wegovy and Ozempic. While these options are effective for different individuals, Paul emphasizes the importance of a comprehensive approach that includes diet and lifestyle changes. As a society, we have normalized obesity, and more education is needed to inform those with obesity about these effective solutions.  Paul explains, "The weight loss drugs people have been hearing about are the first step for weight loss, along with working with your physician and their team. And then as you move down, the more aggressive treatment, the ReShape products, and in particular the Lap-Band®, which has been around for over 20 years, is the first surgical step performed by a laparoscopic surgeon that goes in and helps